FDA official says data integrity issues are the main reason for ANDA delays
Regulatory NewsJoanne S. Eglovitch
GenericsProduct LifecycleSubmission and registrationUnited StatesUS Food and Drug Administration (FDA)Regulatory NewsJoanne S. EglovitchGenericsProduct LifecycleSubmission and registrationUnited StatesUS Food and Drug Administration (FDA)